baber/WOPTO huggingface dataset:
Patent NZ-538738-A (NZ)
Title: Keypad assembly including a lightguide having window protrusions to accommodate LEDs
Inventor: COLEMAN TRAVIS R
IPC: H04Q7/20
Filed: 2005-03-10
Abstract: Disclosed is a keypad assembly for a communicating device comprising a main circuit board for light emitting diodes (LEDs), a keypad board, and a lightguide sandwiched between the main circuit board and keypad board, the lightguide having window protrusions to accommodate the LEDs, the keypad board having openings within which the window protrusions fit in order to provide backlighting and sealing to the communication device.
Patent NZ-545147-A (NZ)
Title: Red/cyan filters for viewing 3D photos printed on home computers and printers
Inventor: RAMADAN SAMER
IPC: G02B27/22
Filed: 2004-07-09
Abstract: A pair of optical filters that are designed and optimized for viewing 3D photos printed on home computer inkjet printers. The pair has a red colored filter having a transmittance (10) of greater than 60 % with 610 nm and greater wavelength light, and a cyan colored filter having a transmittance peak (12) of greater than 60 % with 480 nm wavelength lights and a transmittance of greater than 50 % with 700 nm (14) and greater wavelength.
Patent NZ-549519-A (NZ)
Title: Peptides that activate the guanylate cyclase C (GC-C) receptor for treating gastrointestinal disorders
Inventor: KURTZ CAROLINE
IPC: C07K7/06
Filed: 2005-03-08
Abstract: Disclosed is a polypeptide comprising or consisting of the sequence CCQXCCNPACTGC, wherein X can be F, Y or W. Further disclosed are methods for producing the polypeptide and compositions containing the polypeptide for the treatment of gastrointestinal disorders such as gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease, duodenogastric reflux, Crohn's disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia, and irritable bowel syndrome.
Patent NZ-552750-A (NZ)
Title: Method for drying a gas from a compressorand device applied thereby
Inventor: VANDERSTRAETEN BART ETIENNE AG
IPC: F04B39/16
Filed: 2005-07-28
Abstract: Method for drying a gas from a compressor 1 , for feeding a user network 12 by means of a drier 2 of the type which consists of a pressure tank 3 which is 5 provided with a drying zone 4 and a regeneration zone 5, with a rotor 6 which is composed of a drying element 7 in which is provided an adsorption and/or absorption medium 8 which is alternately put through the drying zone 4 and the regeneration zone 5, wherein at a low load or zero load, the inlet of the regeneration zone 5 is connected to the user network 12 via a regeneration pipe 27, and wherein the outlet of the regeneration zone 5 is connected to the atmosphere, in such a manner that a gas flow is created 25 from the user network 12 through the regeneration zone 5 to the atmosphere, to thus absorb moisture and to evacuate it from the adsorption and/or absorption medium 8 in the above-mentioned regeneration zone 5.
Patent NZ-562164-A (NZ)
Title: Injection device (modified trigger)
Inventor: HABESHAW ROSEMARY LOUISE
IPC: A61M5/20
Filed: 2006-03-21
Abstract: An injection device 110 comprises a housing defining a first axis 101and holding a syringe having a discharge nozzle 122, a trigger 114, and a drive that is acted on and in turn acts upon the syringe. The syringe is movable between a retracted position in which the discharge nozzle is contained within the housing 112 and an extended position in which the discharge nozzle 122 extends from the housing 110. The trigger 114 is activatable to allow the contents of the syringe to be discharged through the discharge nozzle 122. There is also a releasable locking mechanism 116 which, when engaged, prevents the trigger 114 from moving into an active position. The trigger 114 includes a first portion 150 having a cut-out 152 which extends from a first end of the trigger 114a in a direction substantially parallel to the first axis. The releasable locking mechanism 116 includes a protrusion 154 along a second axis for communicating with the first portion 150 of the trigger when the releasable locking mechanism 116 is engaged and for communicating with the cut-out 152 when the releasable locking mechanism 116 is disengaged. When the locking mechanism 116 is in the first locked position and force is applied to the trigger 114, the first portion of the trigger 114 and the protrusion 154 flex in such a way that the protrusion 154 is forced away from the cut-out 152. Such an injection device provides improved protection against accidental activation of the trigger.
Patent NZ-571857-A (NZ)
Title: Junction barrier schottky rectifiers and methods of making thereof
Inventor: MAZZOLA MICHAEL S
IPC: H01L21/04
Filed: 2007-04-03
Abstract: A semiconductor device is disclosed. The semiconductor device comprises a substrate layer comprising a semiconductor material of a first conductivity type and a drift layer on the substrate layer. The drift layer comprises a semiconductor material of the first conductivity type; a central region comprising a plurality of regions of epitaxial semiconductor material of a second conductivity type different than the first conductivity type on a central portion of the drift layer, where the regions of semiconductor material of the second conductivity type have upper surfaces and sidewalls; and a drift region of semiconductor material of the first conductivity type on the drift layer adjacent and between the plurality of regions of semiconductor material of the second conductivity type; an ohmic contact on the substrate layer opposite the drift layer; an ohmic contact on the plurality of regions of the central region; a metal layer on the ohmic contact on the plurality of regions of the central region; and a Schottky metal layer in contact with at least a portion of the drift region, where the Schottky metal layer is electrically connected to the metal layer on the ohmic contact on the central region.
Patent NZ-575874-A (NZ)
Title: A combustion nailer with a control system to control the time between combustion events
Inventor: MOELLER LARRY M
IPC: B25C1/08
Filed: 2006-11-17
Abstract: A combustion nailer, comprising a tool housing; a combustion engine substantially located within the housing and including a valve sleeve reciprocating relative to a cylinder head for cyclically opening and closing a combustion chamber; and a control system associated with the housing and connected to the combustion engine for providing for a designated open time for the combustion chamber after a combustion event and before a subsequent combustion can occur.
Patent NZ-575999-A (NZ)
Title: Imaging Device and Method comprising Lens Arrangement forming Virtual Aperture and Image Capturing Means
Inventor: RANA HARBINDER
IPC: E06B7/30
Filed: 2007-09-24
Abstract: An imaging device suitable for looking through a remote pinhole (2) is disclosed comprising a lens arrangement (1) and an image capturing means (6). The lens arrangement (1) has a plurality of lens elements designed and configured to operate without the presence of an integral physical lens stop. In use the lens arrangement (1) defines a "virtual aperture" in a pre-determined plane in object space remote from its first end. The first end of the lens arrangement (1) is the end closest to the subject being viewed. The virtual aperture acts as a remote entrance pupil in object space beyond the first end of the lens arrangement and defines a pencil of rays (5) that passes through the lens arrangement to the image capturing means (6).
Patent NZ-579208-A (NZ)
Title: Large scale production of TNFR-Fc
Inventor: DRAPEAU DENIS
IPC: C12N1/20
Filed: 2005-08-26
Abstract: Discloses a method of producing TNFR-Ig in a cell culture large-scale production. The method provides for a cell culture comprising: (i) mammalian cells containing a gene encoding TNFR-Ig and a medium containing glutamine and amino acids with characteristics as disclosed (ii) maintaining the culture in an initial growth phase under a first set of culture conditions for a first period of time sufficient to allow cells to reproduce to a viable cell density within a range of about 20%-80% of the maximal possible viable cell density if said culture were maintained under the first set of culture conditions (iii) changing at least one of the culture conditions, so that a second set of culture conditions is applied; maintaining the culture for a second period of time under the second set of conditions and for a second period of time so that TNFR-Ig accumulates in the cell culture. The resulting purified TNFR-Ig protein has therapeutic applications in medicine or for pharmaceutical research.
Patent NZ-580379-A (NZ)
Title: Crystalline anti-human il-12 antibodies
Inventor: BORHANI DAVID W
IPC: C07K16/00
Filed: 2008-03-27
Abstract: Disclosed is a batch crystallization method for crystallizing an anti-human IL-12 antibody, the method comprising the steps of: (a) providing an aqueous crystallization mixture having an aqueous solution of the antibody in admixture with at least one polyalkylene glycol having an average molecular weight in the range of about 400 to about 10,000 as a crystallization agent wherein the antibody concentration is in the range of about 0.5 to about 280 mg/ml; and (b) incubating the aqueous crystallization mixture at a pH of about pH 4 to about 6.5 and at a temperature of about 4o C to about 37o C until crystals of the antibody having a length of about 2-500 ìm are formed. Also disclosed is a crystal of an anti-human IL-12 antibody obtained by a batch crystallization method. Further disclosed is the use of the anti-human IL-12 antibody crystal in the manufacture of a medicament for the treatment of an IL-12 related disorder
Patent NZ-587218-A (NZ)
Title: Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents
Inventor: LI JUNZHONG
IPC: C07C309/12
Filed: 2009-03-27
Abstract: Disclosed is a compound according to Formula I e.g. 10-hydroxy-9-sulfootacdecaneperoxoic acid, 10-dihydroxy-9-sulfooctadecaneperoxoic acid, 9-hydroxy-10-sulfooctadecaneperoxoic acid, and 10-sulfo-8,9-dihydroxyoctadecaneperoxoic acid wherein: R1 is hydrogen, or a Cm alkyl group; R2 is a Cn alkyl group; X is hydrogen, a cationic group, or an ester forming moiety; n is 1 to 10; m is 1 to 10; and m+n is less than or equal to 18, or salts or esters thereof for sanitizing an article.
Patent NZ-587261-A (NZ)
Title: Process for producing thiophene compound and intermediate thereof
Inventor: YANAGIHARA KAZUFUMI
IPC: C07D333/32
Filed: 2009-02-27
Abstract: Disclosed is a process for producing a thiophene compound or an intermediate thereof, wherein the substituents are as described within the specification, which comprises: a) reacting a 2-aryl acetate compound of formula (1) with a thiocetic acid compound of formula (2), to form a thioacetyl compound of formula (3); b) hydrolysing the thioacetly compound, reacting the resulting thiol compound after isolated or without being isolated with a vinyl ketone compound of formula (4), to form a gamma-ketosulfide compound of formula (5); c) cyclizing the gamma-ketosulfide compound under basic conditions to form a dihydrothiophene compound of formula (6); d) and oxidising the dihydrothiophene compound by using an oxidising agent to produce a 2-aryl-3-hydroxy-4-substituted carbonyl thiophene compound of formula (7). Further disclosed is a gamma-ketosulfide compound of formula (5), a dihydrothiophene compound of formula (6), a thioacetyl compound of formula (3), and a thiol compound of formula (8).
Patent NZ-588347-A (NZ)
Title: Cap assembly of a fastner driving tool with mechanism for switching modes of operation.
Inventor: MINA NATHAN T
IPC: B25C1/04
Filed: 2009-03-05
Abstract: A cap assembly (200) for an air actuated fastener-driving tool is disclosed. The cap (200) includes a plurality of fluid ports defined within the cap for conducting actuating air to the working piston and a spool valve (276) reciprocally movable within the cap (200) to permit the fastener driving tool to be operated in two different modes of operation. A switch mechanism (300) is incorporated within said cap member for permitting the spool valve (276) to move reciprocally in an automatic mode of operation when the switch mechanism (300) is in its first position. The spool valve (276) is prevented from moving reciprocally when the switch (300) is in its second position.
Patent NZ-591491-A (NZ)
Title: Sanding apparatus with a cylindrical sanding drum having a splined outer surface to engage a cover
Inventor: ROGERS MARK GRAHAM
IPC: B24D9/04
Filed: 2009-08-20
Abstract: Disclosed is a sanding apparatus comprising a rigid non-expanding cylindrical sanding drum (1) formed with splines on its outer surface (4). The apparatus has a separate cylindrical cover (2) formed of elastomeric material fitted removably onto the drum and formed with splines on its inner surface (8) adapted to engage with the outer surface of the drum so as to be driven in rotation therewith. The cover expands radially when the apparatus is in operation, causing it to grip an abrasive tube (3) which fits over the cover. The abrasive tube is thus driven in rotation by the cover when the apparatus is in operation.
Patent NZ-592446-A (NZ)
Title: Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mrna
Inventor: DE KIMPE JOSEPHUS JOHANNES
IPC: A61K31/7105
Filed: 2009-01-13
Abstract: Provided is a specified antisense oligonucleotide promoting the induction of exon 45 skipping in the dystrophin mRNA. The composition can be used for treating Duchenne muscular dystrophy.
Patent NZ-592578-A (NZ)
Title: A wheelchair with automatic wheelbase extension when the seat is tilted away from upright
Inventor: SCARLETT ROYDON MARK
IPC: A61G5/00
Filed: 2011-04-29
Abstract: A wheelchair with automatic wheelbase extension when the seat is tilted away from upright is disclosed. The wheelchair has a seat support (6) with a seat base and a backrest, the seat support formed so that it can be set in a generally upright disposition and subsequently set in a generally tilted disposition in which both the seat base and backrest are inclined by at least 20° compared to the upright disposition. The wheelchair wheelbase automatically extends as the seat support is moved from the generally upright disposition to the generally tilted disposition (under applied force 18) and then automatically shortens relative to the extended length when the seat support is moved to the generally upright disposition. During this movement the seat base remaining substantially above the axis of rotation of two main large driving wheels of the wheelchair. The wheelchair formed such that when the wheelbase is extended with an occupant within the seat base such occupant's body weight is, in terms of longitudinal positioning, substantially all between the two main large driving wheels (3) of the wheel chair and two smaller forward steering wheels (4) of the wheelchair.
Patent NZ-593816-A (NZ)
Title: Galactose-alpha-1, 3-galactose-containing n-glycans in glycoprotein products derived from cho cells
Inventor: BOSQUES CARLOS
IPC: G01N33/68
Filed: 2009-01-22
Abstract: Disclosed is a method for screening one or more Chinese Hamster Ovary (CHO) cells for the ability to produce glycoproteins comprising glycans containing -alpha-1-3-galactose epitopes, the method comprising: (a) providing a plurality of CHO cell populations wherein none of the plurality have been genetically engineered to produce terminal alpha-galactosyl residues on glycans; (b) culturing each of the plurality of CHO cell populations under conditions suitable for expression of a glycoprotein expression product; (c) measuring glycans containing terminal galactose-alpha-1-3-galactose residues produced by each of the plurality of CHO cells, and (d) selecting one or more of the plurality of CHO cell populations based on the presence of a target level of terminal galactose-alpha-1-3-galactose residues produced by the selected CHO cell population, wherein the CHO cells have not been transfected with an alpha-galactosyl transferase coding sequence.
Patent NZ-595362-A (NZ)
Title: Drive system for a mobile sprayer and/or for a mobile blower
Inventor: TIU DAVID
IPC: A01C15/04
Filed: 2010-03-24
Abstract: A drive system for a mobile blower 11, includes a frame 14, and at least one fan unit 12 for generating an airstream, each fan unit 12 including a fan. The drive system includes a soft start and/or a soft finish, and at least one flexible cable drive 34. In use, the at least one fan unit 12 is attached to the frame 14 and a flexible cable drive 34, the flexible cable drive 34 being engageable with a rotary power source for transferring rotary power from the rotary power source to the at least one fan unit 12 to drive the fan(s).
Patent NZ-597345-A (NZ)
Title: A neural analysis system
Inventor: LITHGOW BRIAN JOHN
IPC: A61B5/04
Filed: 2010-06-24
Abstract: Disclosed is a neural analysis system including a neural event extractor for generating Sp/Ap curve data and field potential data for background and initial response segments obtained from a person (4). The system also includes a correlator for correlating the Sp/Ap curve data and field potential data with pathology data for a condition, and generating biomarker data points for axes of a biomarker display. A display module provides display data to generate the display with the points for use in assessing the person (4) relative to the condition.
Patent NZ-598174-A (NZ)
Title: Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof
Inventor: LASSALLE GILBERT
IPC: C07H15/203
Filed: 2010-08-12
Abstract: 598174 Disclose herein are N-acyl octasaccharide compounds of formula (I), wherein the variables are defined in the specification, in the acid form or in the form of any pharmaceutically acceptable salt thereof. These compounds are useful in the treatment of pathologies requiring activation of the FGF receptors or angiogenesis activation and post-ischaemic revascularisation, such as ischemia or arterial ischemia of the lower limbs and Parkinson’s disease, Alzheimer’s disease, prion disease or neuronal degeneration in alcoholics. Additionally disclosed are protected disaccharide units as intermediates in the synthesis of said octasaccharide compounds.
Patent NZ-603611-A (NZ)
Title: Insulin-like growth factor 1 receptor binding peptides
Inventor: O’NEIL KARYN
IPC: A61K38/00
Filed: 2011-05-25
Abstract: Disclosed is an isolated polypeptide comprising a polypeptide having a sequence selected from the sequences shown in SEQ ID NOs: 1, 2, 4, 8 and 12; wherein the sequences are as disclosed in the specification. Also disclosed is the use of such polypeptides for delivery of a therapeutic agent across endothelial cells.
Patent NZ-603732-A (NZ)
Title: Cell-penetrating peptides and uses therof
Inventor: HAAS ALEXANDER
IPC: C07K14/00
Filed: 2011-06-14
Abstract: Discloses a peptide attached to one or more nucleic acid molecules capable of being internalized into a cell, wherein the peptide molecule a) has a the sequence GMEAAARVYDLGLRRLRQRRRLRRERVRA (SEQ ID NO: 2); which is internalized into a cell with an efficacy being at least 200% of the internalization efficacy of the TAT peptide having the amino acid sequence GRKKRRQRRRPPQ (SEQ ID NO: 1) and wherein the attachment is accomplished by a linkage selected from the group consisting of a covalent linkage and a non-covalent linkage.
Patent NZ-604074-A (NZ)
Title: Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
Inventor: OLSON STEVEN HOWARD
IPC: C07D498/08
Filed: 2011-06-03
Abstract: Disclosed are AMG232 derivatives as represented by the general formula (I), wherein Q is a bond or optionally can be selected from O, NR7 or S(O)v, when n* is an integer from 1 to 6; Z is C=O or S(=O)2; n and n* are each independently selected from 0 or an integer from 1 to 6; R1 is (a) –COOH, –C(O)OR10, –C(O)NHOH, –C(O)NH-NH2, - C(O)NHS(O)2R10, -S(O)2NHC(O)R10, -S(O)2NR7R8, -NR7C(O)R10, –NR7C(O)OR5, -C(O)NR7R8, -NR7S(O)2R10,- NR7C(O) NR7R8, -S(O)vR10, hydroxylalkyl, -cyclopropyl-COOH, or CN; or (b) heteroaryl or heterocyclo, either of which may be optionally independently substituted with one or more Rx groups as allowed by valence; R2 is (a) –NR7R8, NR7C(O)OR10, NR7C(O)NR7R10, or –C(Ra)R5R6; or (b) aryl, heteroaryl, cycloalkyl, or heterocyclo, any of which may be optionally independently substituted with one or more Rx groups as allowed by valence; R3 and R4 are independently aryl or heteroaryl, either of which may be optionally independently substituted with one or more Rx groups as allowed by valence, or either R3 and Ra together with the ring carbon atom to which they are both bonded, or R4 and Rb together with the ring carbon atom to which they are both bonded may optionally combine to form a spiro-fused bicyclic ring system; and wherein the remaining substituents are as defined herein. Representative compounds include 2-(-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid (the specific enantiomer of AMG232 being excluded), 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-cyclopropyl-2-(methylsulfonyl)ethyl)-3-methyl-2-oxopiperidin-3-yl)acetic acid, 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-cyclopropyl-2-(methylsulfonyl)ethyl)-3-methyl-2-oxopiperidin-3-yl)acetic acid, 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3,3-dimethylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid, 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(ethylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid, 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(ethylsulfonyl)butan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid, 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-cyclopropyl-2-(N-phenylcyclopropanesulfonamido)ethyl)-3-methyl-2-oxopiperidin-3-yl)acetic acid, 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-((cyclopropylmethyl)sulfonyl)butan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid, 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-cyclopropyl-2-(methylsulfonyl)ethyl)-3-methyl-2-oxopiperidin-3-yl)acetic acid and 2-(1-(1-(tert-butylsulfonyl)butan-2-yl)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl)acetic acid. Also disclosed is a pharmaceutical composition which comprises a compound as defined above, or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable excipient, diluent or carrier for treating cancer.
Patent NZ-611209-A (NZ)
Title: Environmentally friendly wood treatment process
Inventor: HELLBERG Mårten
IPC: D21H21/36
Filed: 2011-11-28
Abstract: The disclosure relates to a method for the treatment of wooden materials to improve the flame retardant properties and also the resistance to rot, fungus, mold and insects of the wooden material, wherein a wooden material is treated with a water based formulation, comprising the steps: (a) Providing a wooden material; (b) Providing a water based formulation which is stable in room temperature or in temperatures ranging from 15-35 °C, and containing; - an alkali metal silicate, - water - an insolubilization agent which is selected from an organic acid, an inorganic acid or an inorganic polyvalent ion selected from Al3+, Mg2+, Fe2+, Fe3+, Ca2+, Ba2+, or with counter ions CaCl2, MgCl2, FeCl2 or combinations thereof., added in an amount lower than the amount of insolubilization agent needed for the formulation to reach the gelling point; and wherein the weight % of alkali metal silicate compared to the total weight % of the water based formulation can be from 1 % w/w to 50 % w/w, more preferably from 5 % w/w to 30 % w/w and most preferably from 10 % w/w to 20 % w/w, and (c) Applying the water based formulation on the wooden material; and (d) Drying the wooden material treated with said water based formulation at any given temperature in order to remove excess of water; and (e) Curing the dried wooden material at an elevated temperature in order to in solubilize the alkali metal silicate.